Commercial insight into the pharma and biotech sector.
EvaluatePharma and EP Vantage in the Press
February 2010
Biopharmaceuticals: saving the future of our industry - Pharmaceutical Technology Europe, Feb 1, 2010
"...market analysis firm EvaluatePharma has predicted that the top six selling drugs of 2014 will be biotech products, compared with only five in 2008 and one in 2000....In a statement, EvaluatePharma added that the "weight of evidence for a shift to biotech products as the industry's growth driver is overwhelming". more...
January 2010
Novo Hopes for a Diabetes Blockbuster - The Burrill Report, January 30, 2010
"During the last 12 months, predictions for 2010 sales of the drug [Victoza] fell to $591 million from original estimates of $951 million as concerns about potential thyroid cancer risks (based on rodent data) came to the fore, according to EvaluatePharma." more...
December 2009
Risky business - Economist, December 31, 2009
"In 2009, $26 billion of [prescription drug] sales were at risk from patent expiries. This will nearly double in 2011 according to EvaluatePharma..." more...
September 2009
Deals of the Week: Behold the Reimbursement Milestone - The IN VIVO Blog, September 25, 2009
"If the deal [with Leo Pharma] gets Warner out of debt faster...EP Vantage says it’s “reasonably priced” for Leo... EP Vantage notes the deal could be considerably more expensive, however if the acquired pipeline fails to pan out..." more...
Evaluate Ltd receives Queen's Awards for Enterprise: International Trade, 2009 - September 24, 2009
On September 24, 2009, Evaluate Ltd was formally presented with the Queen's Awards for Enterprise: International Trade 2009, by Deputy Lieutenant of London, Commander John Ludgate, in a ceremony at Christchurch, Spitalfields. more...
Glaxo Search for Acquisitions Hampered by 'Desperate' Rivals - Bloomberg, September 24, 2009
"USA Drugs generating $187 billion in sales are threatened by generics between 2011 and 2014 as patents expire, according to EvaluatePharma..." more...
Trust is more than a marketing issue - Pharmaceutical Executive Digest Europe, September 16, 2009
"I...was amazed to discover from the EvaluatePharma database that within less than a week of the first swine flu deaths in April, a staggering $23.2 billion had been added to the value of the world's top anti-viral drugmakers..."more...
EvaluatePharma: Generic players impress in the first half - Generics & Biosimilars Initiative Online, September 14, 2009
"A new analysis of net margins by EvaluatePharma tagged companies for profitability, and the winner was not one of the big pharma companies..."more...
August 2009
PREVIEW-Astra, Boehringer may steal show at heart congress - Reuters, August 24, 2009
"...consensus risk-adjusted forecasts for 2014 Brilinta sales are just $686 million, according to...Evaluate Pharma" more...
Big drug firms embrace generics - Economist, August 6, 2009
"Evaluate Pharma...estimates that about half of the $383 billion-worth of patented drugs to be sold in the world this year will lose patent protection within five years." more...
July 2009
Does Big Pharma still exist? - Pharmaceutical Executive Digest Europe, July 22, 2009
"Figures from EvaluatePharma's World Preview 2014 show generics companies, small companies, biotech companies, any companies that aren't Big Pharma, are all still doing well relative to the performance of traditional Big Pharma." more...
Forget Brand vs. Brand - This is War! - Pharmaceutical Executive, July 1, 2009
"According to market research firm EvaluatePharma, by 2014 Roche will have the most dominant single portfolio in the pharmaceutical industry: Sales of its oncology products are projected to reach $28.3 billion, representing a massive 38 percent of the $75 billion cancer market." more...
Most profitable drugmaker? Not a Big Pharma - FiercePharma, July 1, 2009
"Which pharma is the most profitable? You might be surprised. A new analysis of net margins by EvaluatePharma tagged companies for profitability, and the winner wasn't one of the biggies." more...
June 2009
The Battle Over Biologics Begins - Taking Note, June 29, 2009
"A report from EvaluatePharma...found that “seven of the top 10 drugs in 2014 are forecast to be biotech in origin, compared to five in 2008 and just one in 2000." more...
DotW: Dollars to Donuts - The IN VIVO Blog, June 26, 2009
"...the helpful folks at EP Vantage provided some additional color on the [GSK-Chroma] tie-up..." more...
Sanofi may suffer, whatever final Lantus verdict - Reuters, June 26, 2009
"Most industry analysts expect Lantus to generate sales of around $4 billion this year and consensus forecasts compiled by EvaluatePharma suggest this will rise to $6.4 billion in 2014..." more...
Redefining Pharma - Biotechnology products will dominate industry’s growth - The Burrill Report, June 21, 2009
“EvaluatePharma predicts that biotech drugs will account for half of the 100 top selling drugs by 2014, up from just 11 percent in 2000.”...more...
Top 6 drugs tipped to be biotech products by 2014 - Reuters, June 17, 2009
"Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma." more...
Service Update, Jan '10
January 14th, 2010: EvaluatePharma's industry coverage has grown further with the addition of 88 new companies...
Service Update, December '09
December 11th, 2009: 73 More Companies added to EvaluatePharma®.
Service Update, November '09
November 11th, 2009: 29 More Companies added to EvaluatePharma®.
Service Update, October '09
October 15th, 2009: 30 More Companies added to EvaluatePharma®.
Service Update, September '09
September 16th, 2009: 45 More Companies added to EvaluatePharma®.
Service Update, August '09
August 20th, 2009: 40 More Companies added to EvaluatePharma®.
Service Update, July '09
July 22nd, 2009: 29 More Companies added to EvaluatePharma®.
Service Update, June '09
June 26th, 2009: 43 More Companies added to EvaluatePharma®.
Service Update, May '09
May 29th, 2009: 25 More Companies added to EvaluatePharma®.
Service Update, May '09
April 30th, 2009: 99 More Companies added to EvaluatePharma®.
Service Update, April '09
April 6th, 2009: More Companies added; Q4 and year-end results published
Service Update, March '09
March 4th, 2009: 175 Companies added; Q4 & year-end results published; more service upgrades
Service Update, Jan '09
January 26, 2009: 189 Private Companies added; new feature - Search by Company location